Artificial intelligence (AI) has enormous potential to improve patient outcomes and reduce their variability, making health systems more efficient. But we must take an ethical approach to ensure sustainable implementation and public trust. As leaders in the medical technology sector, we are playing our part in ensuring that our industry develops advanced data-driven technologies in the interest of patients. For us, this is not new: it is in line with our approach to innovation. We begin from an ethical perspective, seeking to improve the lives of people who benefit from the medical technologies we develop. This is a crucial moment in the history of AI in healthcare. Policymakers are looking closely at how to maximise the positive impact of computational science in the age of data while safeguarding privacy and security. We have set out our thinking in two key documents: a paper on Trustworthy Artificial Intelligence in healthcare , in response to the Ethics Guidelines for Trustworthy AI of the European Commission High-Level Expert Group on AI (HLEG AI), and a recently-published MedTech Europe position paper on AI in medtech , addressing the Policy and Investment recommendations of the HLEG AI. These documents set the foundation for our contribution to the upcoming communication of the European Commission on artificial intelligence. Game-changing potential Let’s remind ourselves why this is worth getting right. AI can improve the speed and accuracy of diagnostics and medical imaging; support real-time monitoring and preventative healthcare – intercepting disease in very early stages, sometimes even before it happens. It can also bring a new approach to the delivery of care, optimising the use of healthcare resources, including health professionals’ time; supporting doctors to be at their best and treat patients in better ways than ever before; and empowering patients to manage their well-being. But there is...